<?xml version="1.0" encoding="UTF-8" ?> 

<rss version="2.0"> 
<channel> 
<title>Neurologic Oncology News</title> 
<link>http://www.mdlinx.com/HemeOncLinx/news.cfm/newspage/1/spec_id/17/subspec_id/389</link> 
<description>Neurologic Oncology</description> 
<language>en-us</language> 
<copyright>Copyright 2009 MDLinx, Inc.</copyright>










 



<item> 
<title><![CDATA[Continuous 5-fluorouracil infusion plus long acting Octreotide in advanced well differentiated neuroendocrine carcinomas. A phase II trial of the Piemonte Oncology Network.]]></title> 
<link>http://www.mdlinx.com/HemeOncLinx/xml-article.cfm/2939475</link> 
<pubDate>11/9/2009</pubDate> 
<description><![CDATA[<b>BMC Cancer</b>]]></description> 
<guid>http://www.mdlinx.com/HemeOncLinx/xml-article.cfm/2939475</guid>
</item> 
 

<item> 
<title><![CDATA[Composite paraganglioma-ganglioneuroma in the retroperitoneum]]></title> 
<link>http://www.mdlinx.com/HemeOncLinx/xml-article.cfm/2941702</link> 
<pubDate>11/9/2009</pubDate> 
<description><![CDATA[<b>World Journal of Surgical Oncology</b>]]></description> 
<guid>http://www.mdlinx.com/HemeOncLinx/xml-article.cfm/2941702</guid>
</item> 


 

<item> 
<title><![CDATA[Genome-wide transcriptome analyses reveal p53 inactivation mediated loss of miR-34a expression in malignant peripheral nerve sheath tumours]]></title> 
<link>http://www.mdlinx.com/HemeOncLinx/xml-article.cfm/2940429</link> 
<pubDate>11/9/2009</pubDate> 
<description><![CDATA[<b>The Journal of Pathology</b>]]></description> 
<guid>http://www.mdlinx.com/HemeOncLinx/xml-article.cfm/2940429</guid>
</item> 
 
 


  


</channel> 
</rss>

